Please login to the form below

Deloitte

This page shows the latest Deloitte news and features for those working in and with pharma, biotech and healthcare.

A study published in December by Deloitte showed that R&D costs have doubled in eight years, while peak sales forecasts have halved.

Pharma’s R&D productivity sinks to a new low

The research by Deloitte’s Centre for Health Solutions found returns had declined 1.8 percentage points from 3.7% in 2017. ... Deloitte says the industry needs to tackle the problem with new ways of working and emphasis on finding the right talent.
Artificial intelligence in healthcare

According to a Deloitte report, AI ‘can help analyse large data sets from sources such as clinical trials, health records, genetic profiles and preclinical studies; within this data, it can recognise ... Deloitte also suggests AI can help improve study
NHS bracing for 'no deal’ Brexit impact, including medicines

According to a Deloitte survey, 75% of British companies are now pessimistic about Brexit after weak investment and waning revenues in the most recent financial quarter.
Health insurers will test blockchain for data handling

A Deloitte report on the application of blockchain to healthcare published in 2016 predicted that the technology could “provide a new model for health information exchanges (HIE) by making electronic medical
Pharma is ‘getting lower returns on R&D’

And Deloitte says the number of drugs in late-stage trials tumbled by 16%. ... almost $2bn compared to $1.2bn in 2010 when the annual survey - by Deloitte’s Centre for Health Solutions - was first conducted.

More from news
Approximately 2 fully matching, plus 16 partially matching documents found.

The Big Book of Dashboards

Steve Wexler has worked with ADP, Gallup, Deloitte, Convergys, Consumer Reports, The Economist, ConEd, D&B, Marist, Tradeweb, Tiffany, McKinsey &Company, and many other organisations to help them understand and visualise
The rise of real-world evidence

More than half the leading life science companies polled by Deloitte in 2017 were developing or significantly improving their real-world data (RWD) capabilities.
A quest for innovative solutions

The report from analysts Deloitte in December last year, A New Future for R&D?, highlighted diminishing revenue returns from traditional drug development models but stated: ‘We see opportunities for biopharma
Digitally yours: How to build effective relationships in virtual space

It is not all about saving though. A 2015 Deloitte forecast estimates considerable growth opportunities in the global mobile and digital health market, with a forecasted rise from $2.4 billion
Deal Watch December 2015

December saw the release of reports by two of the top accountancy and consulting groups, PWC and Deloitte. ... Deloitte and GlobalData's report Measuring the return from pharmaceutical innovation 2015 - transforming R&D returns in uncertain times

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Paul Stockdale joins Oxford BioDynamics as CFO

Stockdale arrives at the company from e-Therapeutics, where he had been financial controller since 2012, and has also previously served at Deloitte as a senior manager.
AlixPartners appoints new managing director

Previously healthcare and life sciences partner at Deloitte Consulting, Vogt has experience advising companies in the medtech, healthcare and pharmaceutical industries in implementing and improving strategies. ... Prior to his experience at Deloitte
Sanofi appoints Diane Souza and Thomas Südhof

Prior to this, Souza held the role of chief financial officer at Aetna, overseeing its guaranteed products business, and has also held senior leadership positions at Deloitte and PriceWaterhouseCooper.
Quantum Pharma promotes Chris Rigg to chief financial officer

He brings 20 years of financial and managerial experience to the role, having worked at Deloitte, Eaga, PriceWaterhouseCoopers and Barclays, where he headed up its North East corporate banking division.
David Theil joins Noxilizer as chief financial officer

He has also served as manager of emerging business markets group for Deloitte &Touche where he worked with clients in biotechnology, communications, healthcare and technology companies.

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

More tell, less sell: HCP-centric comms

New York, NY: 2017. 9. Deloitte. Pharma Adoption of Social Media.
Using contextual moments in marketing

Deloitte Digital.
Personas: a top tool for personalising pharma marketing campaigns

Customers’ top healthcare priority in 2018 is receiving personalised care from providers, according to a recent report by Deloitte.
Enablers of drug innovation could lie in the numbers

3) European Central Bank, Eurostat, International Monetary Fund, Deloitte, Haver Analytics, via AllianceBernstein, Institute of Empirical Economical Research, University of Osnabruck.
Huge Untapped Growth Potential of ASEAN

Recent data from a Deloitte industry study show patients in Vietnam’s rural areas spend, on average, less than one-third of the healthcare expenditure by the urban population.